Evaluation and Management of a 24‑mm Cervical Lymph Node

Initial Risk Stratification

• Cervical lymph nodes larger than 1.5 cm are classified as suspicious for malignancy and warrant further work‑up according to the American Academy of Otolaryngology‑Head and Neck Surgery (AAO‑HNS) guidelines. 1
• Nodes measuring 15–25 mm (including a 24 mm node) fall into a high‑risk size category that requires immediate evaluation (Praxis Medical Insights). 2
• Evidence shows that nodes >25 mm are almost always pathologic, whereas nodes ≤15 mm are typically reactive (Praxis Medical Insights). 2

Clinical Features Suggestive of Malignancy

• Hard, fixed consistency of the node is characteristic of malignant disease (AAO‑HNS). 1
• Reduced mobility in both longitudinal and transverse planes raises suspicion for malignancy (AAO‑HNS). 1
• Overlying skin ulceration or invasion indicates a malignant process (AAO‑HNS). 1
• Presence of multiple or matted nodes is associated with malignancy (AAO‑HNS). 1
• Patient risk factors that increase malignancy probability include age > 40 years, tobacco or alcohol use, immunocompromised state, and prior head‑and‑neck cancer (AAO‑HNS). 1
• Associated symptoms that heighten concern are hoarseness, ear pain, hearing loss, intra‑oral swelling or ulceration, dysphagia, odynophagia, weight loss, hemoptysis or blood in saliva, unilateral nasal congestion, and epistaxis (AAO‑HNS). 1

Initial Management When No Suspicious Features Are Present

• Empiric antibiotics should be avoided in the absence of clinical signs of active bacterial infection (e.g., localized warmth, erythema, pain, fever) (Praxis Medical Insights). [3][4]
• Re‑evaluation is recommended at 2 weeks for low‑risk, mobile, soft nodes (Praxis Medical Insights). [3][4]
• If the node persists without complete resolution after 2 weeks, proceed to imaging (Praxis Medical Insights). [3][4]

Imaging Recommendations

• Contrast‑enhanced CT of the neck or contrast‑enhanced MRI of the neck are the first‑line imaging modalities for assessment of suspicious cervical nodes (AAO‑HNS; American College of Radiology, ACR). [1][5]
• These imaging studies provide essential anatomical detail for staging (ACR). 5
• FDG PET/CT should be considered for:
  
  • Staging of advanced disease (stage III–IV) (ACR). 5
  • Identifying an unknown primary tumor when cervical metastasis is present (sensitivity ≈ 69 % vs 15 % with CT alone) (ACR). 5
  • Evaluating distant metastases, offering a negative predictive value of 99 % (ACR). 5

Referral to Otolaryngology‑Head and Neck Surgery (ENT)

• Immediate ENT referral is indicated for nodes with malignant characteristics (fixed, hard, >1.5 cm, ulcerated) (Praxis Medical Insights). [3][2]
• Referral is also warranted for persistence ≥2 weeks, emergence of systemic symptoms (fever, night sweats, weight loss), or lack of response to an appropriate antibiotic course within 48–72 hours (Praxis Medical Insights). [3][4]

Tissue Diagnosis

• Fine‑needle aspiration (FNA) with a thin needle is the preferred initial method for obtaining tissue from a suspicious cervical node, superseding open biopsy (Praxis Medical Insights). 3
• When malignancy is strongly suspected, an upper aerodigestive tract examination under anesthesia should be performed before any open surgical biopsy (Praxis Medical Insights). 3

Common Pitfalls to Avoid

• Do not prescribe repeated courses of antibiotics without clear evidence of bacterial infection, as this may mask an underlying malignancy (Praxis Medical Insights). [3][4]
• Do not assume a cystic neck mass is benign; HPV‑positive carcinomas can present as cystic lesions (AAO‑HNS). 1
• Partial resolution of lymphadenopathy does not exclude malignancy and should prompt further evaluation (Praxis Medical Insights). [3][4]
• Relying solely on size is insufficient; a comprehensive assessment integrating clinical features, imaging, and, when needed, tissue sampling is essential for definitive diagnosis (AAO‑HNS; Praxis Medical Insights). [1][2]

Follow‑up and Monitoring

• If the lymph node completely resolves, schedule an additional follow‑up visit in 2–4 weeks to confirm sustained remission (Praxis Medical Insights). 4
• Even when imaging suggests a benign process, ongoing clinical evaluation should continue until a definitive diagnosis is established (Praxis Medical Insights). 3
• Patients should be instructed to return promptly if new systemic symptoms develop or if the node enlarges (Praxis Medical Insights). 4

Imaging Recommendation: Chest Radiography

Radiographic Evaluation

• Chest radiography is recommended to assess for synchronous bronchial tumors or mediastinal involvement in patients presenting with cervical lymph nodes up to 20 mm in size. 6